Targeting Drug Memories With Methylphenidate
Study Phase: Early Phase 1
Recruitment Status: Recruiting
Start Date: July 05, 2023
End Date: August 31, 2024
Inclusion criteria:
- Ability to understand and give informed consent
- Males and females 26-50 years of age
- DSM-V diagnosis for CUD or otherwise problematic cocaine use as clinically determined
Exclusion criteria:
- DSM-5 diagnosis for schizophrenia or developmental disorder (e.g., autism)
- Head trauma with loss of consciousness
- History of neurological disease of central origin including seizures
- Cardiovascular disease including high blood pressure and/or other medical conditions, including metabolic, endocrinological, oncological or autoimmune diseases, and infectious diseases including Hepatitis B and C or HIV/AIDS
- Metal implants or other MR contraindications
-
Conditions:
- Substance-Related Disorders